SE505274C2 - Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning - Google Patents

Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning

Info

Publication number
SE505274C2
SE505274C2 SE9503731A SE9503731A SE505274C2 SE 505274 C2 SE505274 C2 SE 505274C2 SE 9503731 A SE9503731 A SE 9503731A SE 9503731 A SE9503731 A SE 9503731A SE 505274 C2 SE505274 C2 SE 505274C2
Authority
SE
Sweden
Prior art keywords
zeolite
solution
use according
syringe
hydrophobic
Prior art date
Application number
SE9503731A
Other languages
English (en)
Swedish (sv)
Other versions
SE9503731D0 (sv
SE9503731L (sv
Inventor
Sten Andersson
Haakan Eriksson
Kaare Larsson
Original Assignee
Sten Andersson
Haakan Eriksson
Larsson Kare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sten Andersson, Haakan Eriksson, Larsson Kare filed Critical Sten Andersson
Priority to SE9503731A priority Critical patent/SE505274C2/sv
Publication of SE9503731D0 publication Critical patent/SE9503731D0/xx
Priority to EP96935707A priority patent/EP0956155B1/de
Priority to AT96935707T priority patent/ATE222802T1/de
Priority to PCT/SE1996/001306 priority patent/WO1997015391A1/en
Priority to DE69623354T priority patent/DE69623354T2/de
Priority to AU73524/96A priority patent/AU693047B2/en
Priority to JP9516525A priority patent/JPH11514920A/ja
Priority to CA002235767A priority patent/CA2235767A1/en
Priority to US09/051,752 priority patent/US5936061A/en
Publication of SE9503731L publication Critical patent/SE9503731L/xx
Publication of SE505274C2 publication Critical patent/SE505274C2/sv

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
    • B01J20/16—Alumino-silicates
    • B01J20/18—Synthetic zeolitic molecular sieves
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00—Aspects relating to sorbent materials
    • B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
    • B01J2220/64—In a syringe, pipette, e.g. tip or in a tube, e.g. test-tube or u-shape tube

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Water Supply & Treatment (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
SE9503731A 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning SE505274C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9503731A SE505274C2 (sv) 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning
US09/051,752 US5936061A (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
DE69623354T DE69623354T2 (de) 1995-10-24 1996-10-15 Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung
AT96935707T ATE222802T1 (de) 1995-10-24 1996-10-15 Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung
PCT/SE1996/001306 WO1997015391A1 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
EP96935707A EP0956155B1 (de) 1995-10-24 1996-10-15 Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung
AU73524/96A AU693047B2 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
JP9516525A JPH11514920A (ja) 1995-10-24 1996-10-15 ポリペプチド溶液から防腐剤を除去するための疎水性ゼオライトの使用、シリンジおよび方法
CA002235767A CA2235767A1 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9503731A SE505274C2 (sv) 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning

Publications (3)

Publication Number Publication Date
SE9503731D0 SE9503731D0 (sv) 1995-10-24
SE9503731L SE9503731L (sv) 1997-04-25
SE505274C2 true SE505274C2 (sv) 1997-07-28

Family

ID=20399935

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9503731A SE505274C2 (sv) 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning

Country Status (9)

Country Link
US (1) US5936061A (de)
EP (1) EP0956155B1 (de)
JP (1) JPH11514920A (de)
AT (1) ATE222802T1 (de)
AU (1) AU693047B2 (de)
CA (1) CA2235767A1 (de)
DE (1) DE69623354T2 (de)
SE (1) SE505274C2 (de)
WO (1) WO1997015391A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037364A1 (en) * 1998-12-09 2000-06-29 Ordio Ab Purification of water

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802140D0 (sv) * 1998-06-16 1998-06-16 Ordio Ab Zeoliter för adsorption
US6589224B2 (en) * 2001-02-14 2003-07-08 Renal Tech International Llc Method of introducing fluids into a patient's body
US20050031708A1 (en) * 2003-08-06 2005-02-10 Portney Micah S. Composition comprising a zeolite compound for treatment of diseases
EP1989304B1 (de) * 2006-02-24 2010-05-05 Novo Nordisk Health Care AG Verfahren zur entfernung eines nichtmetallischen proteinhemmers aus einer flüssigen pharmazeutischen zubereitung
CA2574746A1 (en) * 2007-01-22 2008-07-22 Duoject Medical Systems Inc. Syringe having venting structure and method for mixing two substances in a syringe
WO2009027478A2 (en) * 2007-08-29 2009-03-05 Novo Nordisk Health Care Ag A method of removing preservatives from a liquid pharmaceutical preparation
US10405961B2 (en) 2013-03-14 2019-09-10 Cell and Molecular Tissue Engineering, LLC Coated surgical mesh, and corresponding systems and methods
US10130288B2 (en) 2013-03-14 2018-11-20 Cell and Molecular Tissue Engineering, LLC Coated sensors, and corresponding systems and methods
WO2016025560A1 (en) 2014-08-13 2016-02-18 University Of Florida Research Foundation, Inc. Preservative removal from eye drops
US10780222B2 (en) 2015-06-03 2020-09-22 Pacific Diabetes Technologies Inc Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives
CA3018985C (en) * 2016-04-22 2021-11-16 Eli Lilly And Company Infusion site passivating device for extended wear during continuous subcutaneous insulin infusion (csii)
WO2018204327A1 (en) * 2017-05-01 2018-11-08 Becton, Dickinson And Company Filter for reducing phenolic compounds from insulin and related infusion and injection devices
CA3066399A1 (en) 2017-06-08 2018-12-13 Amgen Inc. Torque driven drug delivery device
JP7517996B2 (ja) * 2018-04-27 2024-07-17 ベクトン・ディキンソン・アンド・カンパニー 送達デバイスおよび吸着剤
WO2019236653A1 (en) * 2018-06-06 2019-12-12 Entopsis Llc System and method for removing phenolic preservations from insulin formulations
IL293976A (en) 2019-12-19 2022-08-01 Tearclear Corp Preservative removal from eye drops
AU2021322232A1 (en) * 2020-08-05 2023-03-23 TearClear Corp. Systems and methods for preservative removal from ophthalmic formulations
CN122376921A (zh) 2020-08-23 2026-07-14 太平洋糖尿病科技公司 用于递送胰岛素或胰岛素类似物制剂和测量皮下葡萄糖浓度的装置
US20230414865A1 (en) * 2022-06-23 2023-12-28 Insulet Corporation Wearable drug delivery device with incorporated filtration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240986A (en) * 1979-02-23 1980-12-23 Uop Inc. Process for the separation of ortho-chloronitrobenzene
DE3060548D1 (en) * 1979-06-18 1982-08-05 Pq Corp Agglomerated zeolite ion exchanger
SE8902919L (sv) * 1989-09-05 1991-03-05 Haakan Eriksson Anvaendning av zeoliter som adsorbenter av detergenter i biokemiska/biotekniska system och processer
SE9201976D0 (sv) * 1992-06-26 1992-06-26 Tektolit Ab Haakan Eriksson En metod foer att adsorbera proteiner och peptider till hydrofoba zeoliter
US5314855A (en) * 1992-11-09 1994-05-24 Akzo N.V. Adsorbent compositions and methods of manufacture
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037364A1 (en) * 1998-12-09 2000-06-29 Ordio Ab Purification of water

Also Published As

Publication number Publication date
SE9503731D0 (sv) 1995-10-24
DE69623354T2 (de) 2003-01-09
JPH11514920A (ja) 1999-12-21
SE9503731L (sv) 1997-04-25
CA2235767A1 (en) 1997-05-01
DE69623354D1 (de) 2002-10-02
EP0956155A1 (de) 1999-11-17
EP0956155B1 (de) 2002-08-28
AU693047B2 (en) 1998-06-18
AU7352496A (en) 1997-05-15
WO1997015391A1 (en) 1997-05-01
US5936061A (en) 1999-08-10
ATE222802T1 (de) 2002-09-15

Similar Documents

Publication Publication Date Title
AU693047B2 (en) Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
AU621148B2 (en) Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
DE69027187T2 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
AU698154B2 (en) System for viral inactivation of blood
US20110027257A1 (en) Clottable concentrate of platelet growth factors and preparation method thereof
JP2000513377A (ja) プリオンのクロマトグラフィー除去方法
EP2389942A1 (de) Viral inaktives wachstumsfaktorhaltiges PDGF- und VEGF-armes Plättchenlysat und Herstellungsverfahren dafür
EP0668877A1 (de) Verdrängungschromatographisches verfahren und gereinigtes hämoglobin
RU2719468C2 (ru) Способы очистки и/или вирусной инактивации
KR890006251A (ko) 고-순도의, 바이러스로부터 보호된 생물학적 활성 트랜스페린 제제의 제조방법
SK54993A3 (en) Imidoester cross-linked hemoglobin compositions
Austen The chromatographic separation of factor VIII on aminohexyl sepharose
WO2004067549A2 (de) Peptide gegen kälteunverträglichkeit hervorrufende autoantikörper und ihre verwendung
KR100361894B1 (ko) 치환크로마토그라피방법및정제된헤모글로빈생성물
Ramanathan et al. Antiviral principles of propionibacteria-isolation and activity of propionins B and C
CN100569287C (zh) 犬静脉注射免疫球蛋白、其制备方法以及犬静脉注射免疫球蛋白制剂
EP1684868B1 (de) Bekämpfung von hi-virus infektionen mit durch hypochlorige säure oxidiertem menschlichem blutplasma
EP1048307B1 (de) Dialysemembran für Herstellung von Inhibitor der Blutbildung enthaltenden Zusammensetzungen
RU2140287C1 (ru) Способ получения альбумина
Gebauer et al. Ion-exchange chromatography separation of the detergent and the solvent from immunoglobulins after solvent–detergent treatment
CA1303295C (en) Immunosuppressor and method of extraction thereof
TW201319084A (zh) 血小板源腦源性神經滋養因子濃厚液及其製備方法
DE10311106A1 (de) Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper und ihre Verwendung
DE19616540A9 (de) Verwendung von von Willebrand-Faktor und pharmazeutische Zubereitung

Legal Events

Date Code Title Description
NUG Patent has lapsed